FDAFDA · Food and drugs·Recall number D-1335-2022
Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactured for Heron Therapeutics, Inc., San Diego, CA, NDC 47426-301-02
Published August 24, 2022 · Recall initiated: August 2, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- ZYNRELEF
- Manufacturer
- HERON THERAPEUTICS, INC.
- Distributor
- U.S.A. Nationwide
- Lot
- Lot #: 01126739, Exp 7/31/2023
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.